m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00084)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
UBA6-DT
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
RNA-binding motif protein 15 (RBM15) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by RBM15 | ||
Cell Line | Human BJ Fibroblast | Homo sapiens |
Treatment: siRBM15 BJ fibroblast
Control: siControl BJ fibroblast
|
GSE154148 | |
Regulation |
|
logFC: -3.20E+00 p-value: 2.22E-06 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | IGF2BP1 was identified as the m6A reader protein of UBA6 divergent transcript (UBA6-DT/UBA6-AS1)-RBM15-mediated m6A modification of UBA6 mRNA, which enhanced the stability of UBA6 mRNA. UBA6-AS1 suppressed the proliferation, migration and invasion of OC cells via UBA6. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
In-vitro Model | SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 |
OVCAR-3 | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0465 | |
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | IGF2BP1 was identified as the m6A reader protein of UBA6 divergent transcript (UBA6-DT/UBA6-AS1)-RBM15-mediated m6A modification of UBA6 mRNA, which enhanced the stability of UBA6 mRNA. UBA6-AS1 suppressed the proliferation, migration and invasion of OC cells via UBA6. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Ovarian cancer | ICD-11: 2C73 | ||
In-vitro Model | SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 |
OVCAR-3 | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0465 | |
Ovarian cancer [ICD-11: 2C73]
In total 3 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [] | |||
Response Summary | In ovarian cancer, a prognostic signature containing four LI-m6As (AC010894.3, ACAP2-IT1, CACNA1G-AS1, and UBA6 divergent transcript (UBA6-DT/UBA6-AS1)) was constructed according to the LASSO Cox regression analysis of the 10 LI-m6As. | |||
Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | IGF2BP1 was identified as the m6A reader protein of UBA6 divergent transcript (UBA6-DT/UBA6-AS1)-RBM15-mediated m6A modification of UBA6 mRNA, which enhanced the stability of UBA6 mRNA. UBA6-AS1 suppressed the proliferation, migration and invasion of OC cells via UBA6. | |||
Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | ||
Target Regulation | Up regulation | |||
In-vitro Model | SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 |
OVCAR-3 | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0465 | |
Experiment 3 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | IGF2BP1 was identified as the m6A reader protein of UBA6 divergent transcript (UBA6-DT/UBA6-AS1)-RBM15-mediated m6A modification of UBA6 mRNA, which enhanced the stability of UBA6 mRNA. UBA6-AS1 suppressed the proliferation, migration and invasion of OC cells via UBA6. | |||
Responsed Disease | Ovarian cancer [ICD-11: 2C73] | |||
Target Regulator | RNA-binding motif protein 15 (RBM15) | WRITER | ||
Target Regulation | Up regulation | |||
In-vitro Model | SK-OV-3 | Ovarian serous cystadenocarcinoma | Homo sapiens | CVCL_0532 |
OVCAR-3 | Ovarian serous adenocarcinoma | Homo sapiens | CVCL_0465 | |